Synthetic cannabinoids: the multi-organ failure and metabolic derangements associated with getting high

Synthetic cannabinoids (SC), though not detected with routine urine toxicology screening, can cause severe metabolic derangements and widespread deleterious effects in multiple organ systems. The diversity of effects is related to the wide distribution of cannabinoid receptors in multiple organ syst...

Full description

Saved in:
Bibliographic Details
Published in:Journal of community hospital internal medicine perspectives 2015-01, Vol.5 (4), p.27540-6
Main Authors: Sherpa, Dolkar, Paudel, Bishow M, Subedi, Bishnu H, Chow, Robert Dobbin
Format: Article
Language:English
Subjects:
Case Report
JWH-018
JWH-073
multiorgan failure
reversible cardiomyopathy
rhabdomyolysis
Spice
STEMI
subarachnoid hemorrhage
Synthetic Cannabinoids
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Synthetic cannabinoids (SC), though not detected with routine urine toxicology screening, can cause severe metabolic derangements and widespread deleterious effects in multiple organ systems. The diversity of effects is related to the wide distribution of cannabinoid receptors in multiple organ systems. Both cannabinoid-receptor-mediated and non-receptor-mediated effects can result in severe cardiovascular, renal, and neurologic manifestations. We report the case of a 45-year-old African American male with ST-elevation myocardial infarction, subarachnoid hemorrhage, reversible cardiomyopathy, acute rhabdomyolysis, and severe metabolic derangement associated with the use of K2, an SC. Though each of these complications has been independently associated with SCs, the combination of these effects in a single patient has not been heretofore reported. This case demonstrates the range and severity of complications associated with the recreational use of SCs. Though now banned in the United States, use of systemic cannabinoids is still prevalent, especially among adolescents. Clinicians should be aware of their continued use and the potential for harm. To prevent delay in diagnosis, tests to screen for these substances should be made more readily available.
ISSN:2000-9666
2000-9666
DOI:10.3402/jchimp.v5.27540